Table 3.
Clinical characteristics of the male group
| AD[−DM] | AD[+DM] | DrD | |
|---|---|---|---|
| Subjects, n | 43 | 27 | 18 |
| Age, years | 83.3±4.8 | 81.1±4.3 | 83.4±4.9 |
| Duration of dementia, years | 2.9±0.9 | 3.0±0.9 | 3.0±0.7 |
| Education, years | 14.4±2.2 | 13.9±2.5 | 13.8±2.4 |
| HbA1c, % | 5.8±0.3 | 7.4±1.1* | 7.3±1.0* |
| Long duration of diabetes (≥15 years), n (%) | - | 10 (37) | 8 (44) |
| Insulin therapy, n (%) | - | 7 (26) | 5 (28) |
| MMSE score | 21.1±2.6 | 21.8±3.5 | 22.6±2.4 |
| Charlson comorbidity index | 1.5±0.6 | 2.3±0.6* | 2.3±0.5* |
| Body mass index | 22.7±2.6 | 23.9±3.4 | 24.3±3.4 |
Values are presented as the mean ± SD unless specified otherwise. For explanations of the abbreviations, see footnote to Table 1.
*
p < 0.0001 compared with AD[−DM].